Hon ANDREW LITTLE: That is that part, OK. Then, in that respect, that is the regime that requires accurate and appropriate harm reduction information to be given, as the member will see, and then lays out in that subsection (2), in those various bits and pieces there, how the approach is to be taken. So if the test indicates the likely identity, then the advice should be about that specific drug that the person has surrendered for testing. Now, if the test doesn't indicate the likely identity of the drug or substance but the provider considers that they are able to form a view on its likely identity, then the drug checking service can provide information on that drug or substance that they think that it is and the harms associated with that particular drug or substance. And in any other case where the test doesn't indicate the likely identity of the drug or substance, nevertheless the harms associated with taking a drug or substance of an unknown identity. So it covers all those off. This is about the person who takes their drugs in for checking getting some information either about the specific substance that they know that is tested positive or general information about the risks associated with drug taking generally.